Skip to main content
SLCO1B1

SLCO1B1

ProteinWikipedia

Search complete. 4 mentions across 3 episodes found for "SLCO1B1".

Oct 21, 2026

Anil BajnathGUEST
7:05
There's other applications, including pharmacogenomics and looking at whether or not you're gonna respond favorably or unfavorably to a drug or medication or intervention, and that's very clinically relevant.
Anil BajnathGUEST
7:18
You know, um, statins, one of the most prescribed drugs and medications in the world, there's a certain genetic, uh, genotype, SLCO1B1, that's associated with being statin intolerant, and that risk for myopathy is increased.
Anil BajnathGUEST
7:34
So very important, you know, for all those folks that are out there, and they're like, "Hey, I started a statin, and unfortunately, like my-- I-- fatigue and muscle and all..." Very important clinical molecular association that's not oftentimes looked at.
Anil BajnathGUEST
7:47
And there are other, you know, nutrigenomic, uh, clinical applications in looking at how your genes responds to micronutrients and how micronutrients respond to your genes.
Ethan Hausman-MarquisHOST
12:06
Most clinicians have never opened one.
Ethan Hausman-MarquisHOST
12:08
Concrete examples: SLCO1B1 encodes a transporter that moves statins into the liver.
Ethan Hausman-MarquisHOST
12:16
Reduced function variants mean the drug lingers in circulation and in muscle instead, and muscle exposure is what produces statin myopathy.
Ethan Hausman-MarquisHOST
12:25
There is a large population walking around convinced they are statin intolerant who are in fact intolerant of that statin at that dose and would do perfectly well on a different agent.

14 MINS LATER

Ethan Hausman-MarquisHOST
26:11
Two previous statin attempts, both abandoned for muscle pain.
Ethan Hausman-MarquisHOST
26:15
She had concluded she was statin intolerant, and her previous physicians had accepted that.
Ethan Hausman-MarquisHOST
26:20
ApoB elevated, LPA elevated, pharmacogenomics, SLCO1B1 reduced function variant.
Ethan Hausman-MarquisHOST
26:26
She was not statin intolerant.
John BazarHOST
4:09
It's a new drug, so we don't have a lot of real-world data, but there are precautions with either strong or moderate 3-4 inducers or inhibitors.
John BazarHOST
4:19
It also inhibits P-glycoprotein, MATE1, MATE2K, OCT1, OCT2, OATP1B1, OATP1B3, breast cancer resistant protein, and BSEP, which is a transport protein I've never heard of.
John BazarHOST
4:30
So it does inhibit a lot of other transporters and has a risk for other interactions.
John BazarHOST
4:36
This inhibition of, like I say, OCT2 and MATE1 is probably why you see creatinine increased in 52%.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.